• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astrazeneca Pharma India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 39.0
  • ISIN : INE203A01020
8,607.65 113 (1.33%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    8,430.30

  • Today’s High

    8,759.00

  • Open

    8,510.00

  • Perv Close

    8,494.65

  • 52W Low

    4,800.15

  • 52W High

    9,059.05

Key Indicators

  • P/E(TTM)

    128.36

  • Mar.Cap (₹Cr.)

    21,519.13

  • Div & Yield %

    0.28

  • Book Value(₹)

    271.74

  • Debt-Equity Ratio

    1.33

  • AGM Date

    28-Mar-2025

  • EPS

    67.05

  • P/E Ratio

    128.36

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    21,519.13

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.00

  • BV (₹)

    271.70

  • Sales( ₹ in Cr.)

    1,295.53

  • NP (in Cr.)

    149.06

  • NP Var(%)

    18.0

  • Div%

    1200.0

  • CPS (₹)

    65.60

  • EPS (₹)

    59.60

  • Traded Value (₹ in Lakhs)

    21,515.88

  • 52 Week High

    9,059.05

  • 52 Week Low

    4,800.15

  • Price BSE

    8606.0

  • Price NSE

    8,608.00

  • Market Capital( in Cr.)

    21,515.88

  • P/C Ratio

    131.20

  • P/E Ratio

    144.30

  • Price Vs.BV

    59.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,295.53 1,002.97 805.60 813.56 831.81 728.29
Excise Duty 1,205.64 941.75 761.42 776.79 801.26 683.31
Net Sales 1,295.53 1,002.97 805.60 813.56 831.81 728.29
Other Income 34.80 26.10 14.76 12.84 12.99 16.29
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,330.33 1,029.07 820.36 826.40 844.80 744.58
EXPENDITURE :
Raw Materials 1,205.64 941.75 761.42 776.79 801.26 683.31
Power & Fuel Cost 1,205.64 941.75 761.42 776.79 801.26 683.31
Employee Cost 241.45 259.10 230.21 219.54 216.70 197.40
Other Manufacturing Expenses 21.49 13.72 16.01 17.40 15.24 12.22
Selling & Administrative Expenses 234.33 185.72 145.09 129.72 157.18 198.14
Miscellaneous Expenses 21.49 13.72 16.01 17.40 15.24 12.22
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,127.22 854.74 737.32 699.31 730.83 671.91
Operating Profit 19.25 19.33 16.15 16.48 16.76 18.10
Interest 1.20 0.63 0.95 1.09 1.14 0.00
Gross Profit 219.54 134.10 83.04 127.09 113.97 72.67
Depreciation 14.94 16.26 16.95 20.13 18.58 14.92
Profit Before Tax 219.54 134.10 83.04 127.09 113.97 72.67
Tax 53.55 38.30 22.63 34.83 31.51 16.68
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.90 -3.49 -1.19 -1.04 10.25 1.54
Reported Net Profit 161.51 99.29 61.60 93.30 72.21 54.45
Extraordinary Items 219.54 134.10 83.04 127.09 113.97 72.67
Adjusted Net Profit 161.51 99.29 61.60 93.30 72.21 54.45
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 60.00 40.00 25.00 5.00 2.50 0.00
P & L Balance carried down 161.51 99.29 61.60 93.30 72.21 54.45
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 1,200.00 800.00 500.00 100.00 50.00 0.00
Dividend Per Share(Rs) 24.00 16.00 10.00 2.00 1.00 0.00
Earnings Per Share-Unit Curr 64.60 39.70 24.60 37.30 28.90 21.80
Book Value 60.00 40.00 25.00 5.00 2.50 0.00
Book Value(Adj)-Unit Curr 60.00 40.00 25.00 5.00 2.50 0.00

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 18,750,000 75.00 18,750,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 18,750,000 75.00 18,750,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 375 0.00 250 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 731,422 2.93 731,422 95
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 32,120 0.13 32,120 3
Mutual Funds / UTI 1,261,191 5.04 1,261,191 40
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,342 0.05 11,342 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,036,450 8.15 2,036,325 147
2] Non Institution
Bodies Corporate 333,333 1.33 333,333 211
Clearing Members 129 0.00 129 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 85,899 0.34 85,399 796
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,639,112 6.56 1,639,112 7
Individuals holding nominal share capital up to Rs. 1 lakh 2,014,937 8.06 1,887,482 26,149
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 10,163 0.04 10,163 5
Others 104,307 0.42 104,307 2
Sub Total 4,213,550 16.85 4,085,595 27,174
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 25,000,000 100.00 24,871,920 27,322

Company Background

Astrazeneca Pharma India LtdPharmaceuticals - Multinational

  • Astrazeneca Pharma India Ltd
  • BSE Code : 39.0
  • ISIN : INE203A01020

  • Incorporation Year

    1979

  • Registered Office

    Blk N1 12th Flr Manyata Embass
    Rachenahalli Outer Ring Road, Bangalore,
    Karnataka-560045

  • Telephone

    91-080-67748000

  • FAX

    91-080-67748557

  • Chairman

    Narayan K Seshadri

  • Managing Director

    Sanjeev Panchal

  • Company Secretary

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Enterprises (I) Ltd
    No. 30 Ramana Resid.,
    4th Cross Sampige Rd,Malleswaram
    Mumbai - Bangalore - 560003

Astrazeneca Pharma India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Novartis India 785.05 396.75 335.07 22.47 15.57
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92